Microbio Co

Microbio Co Enterprise Value

The Enterprise Value (EV) of Microbio Co (4128.TWO) as of Oct 23, 2026 is 10.69 B TWD. In the previous year, Enterprise Value (EV) was 11.31 B TWD — a change of -5.45% (lower).

Enterprise Value

10.69 BTWD

YoY

-5.45%

Last updated:

Enterprise Value (EV) of Microbio Co is 2025 10.69 B TWD. Enterprise Value (EV) of Microbio Co was 2024 11.31 B TWD. It decreases by -5.45% lower compared to the previous year.

The Microbio Co Enterprise Value history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Enterprise Value
Date
Enterprise Value
Jan 1, 2018
5.86 B TWD
Jan 1, 2019
7.01 B TWD
Jan 1, 2020
7.01 B TWD
Jan 1, 2021
7.15 B TWD
Jan 1, 2022
7.08 B TWD
Jan 1, 2023
7.65 B TWD
Jan 1, 2024
11.31 B TWD
Jan 1, 2025
10.69 B TWD
The Microbio Co Enterprise Value history
YEAREnterprise ValueYoY
10.69 BTWD-5.45%
11.31 BTWD+47.81%
7.65 BTWD+8.10%
7.08 BTWD-0.99%
7.15 BTWD+1.95%
7.01 BTWD-0.03%
7.01 BTWD+19.65%
5.86 BTWD-21.50%
7.47 BTWD+3.85%
7.19 BTWD+4.43%
6.88 BTWD+7.98%
6.38 BTWD—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Microbio Co Stock analysis

What does Microbio Co do? Microbio Co., Ltd. generates revenue through the sale of fermentation products like Tien Chun Bao (TCB) oral solutions, herbal products such as the LeeHerb series, and organic foods including vegetables, fruits, nuts, pastry, seasonings, and organic meals. The company also sells new medicines, including anticancer drugs, hepatitis treatments, allergy medications, and rheumatoid arthritis therapies. Domestic market sales form the primary distribution channel for all product lines. The firm targets consumers seeking natural health solutions through its Tien Chun Bao and LeeHerb product lines, while healthcare professionals and patients requiring specialized treatments purchase its new medicines. Organic food buyers include health-conscious individuals and households looking for sustainable dietary options. All products are sold within Taiwan's domestic market, with no international distribution mentioned. Microbio Co., Ltd. focuses on three core product segments: fermentation-based health solutions, herbal healthcare products, and organic food items. The anticancer and hepatitis medicine segments serve medical professionals and patients in Taiwan, while allergy and rheumatoid arthritis treatments target specific patient groups. The company's product portfolio is fully contained within Taiwan's domestic market, with no indication of international expansion. Microbio Co is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Microbio Co stock

Enterprise Value (EV) of Microbio Co is 10.69 B TWD in 2025.

Enterprise Value (EV) of Microbio Co changed from 11.31 B TWD to 10.69 B TWD, representing a -5.45% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Enterprise Value (EV) Microbio Co since 2006 – with annual values, charts, and detailed analysis.

Enterprise Value represents the total value of a company, including both equity and debt, minus cash. It provides a more comprehensive picture than market capitalization alone.

EV = Market Capitalization + Total Debt - Cash & Equivalents

To evaluate Enterprise Value (EV)'s TWD, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for Enterprise Value (EV).

A 'good' TWD varies by industry and company stage. On Eulerpool, you can compare Enterprise Value (EV)'s Microbio Co with sector peers and the industry average to assess whether it is attractive.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Valuation — Microbio Co

All Key Metrics — Microbio Co